Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs ↧ ↧ Lilly says Foundayo has captured over 30% of new US patients on or... Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early lead gained by Danish rival Novo Nordisk with its Wegovy pill.
published
Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs ↧
Open the original public source →
Latest documented BWB result
$APP market result
I Sold the $APP $310 Puts for Friday for $3 - been selling Puts on $APP every week with that hard floor of $300 and the high premium
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.